AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (November 6, 2001). doi:10.1152/ajpendo.00124.2001
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/3/E522    most recent
00124.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Catalano, P. M
Right arrow Articles by Friedman, J. E
Right arrow Search for Related Content
PubMed
Right arrow Articles by Catalano, P. M
Right arrow Articles by Friedman, J. E

Articles in PresS, published online ahead of print November 5, 2001
Am J Physiol Endocrinol Metab, 10.1152/ajpendo.00124.2001
Submitted on March 16, 2001
Accepted on October 31, 2001

Down-regulated IRS-1 and PPAR {gamma} in Obese Women with GDM: Relationship to Free Fatty Acids during Pregnancy

Patrick M Catalano1, Steve E Nizielski2, Jianhua Shao1, Larraine Preston1, Liping Qiao1, and Jacob E Friedman1*

1 Reproductive Biology and Nutrition, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
2 Nutrition, Texas A&M University, College Station, Texas, USA

* To whom correspondence should be addressed. E-mail: jed.friedman{at}uchsc.edu.

Gestational Diabetes Mellitus (GDM) is associated with elevated post-prandial free fatty acids (FFA) and insulin resistance, however little is known about the cellular mechanisms underlying insulin resistance to suppress lipolysis during gestation. We evaluated the longitudinal changes in basal maternal FFA concentration and insulin suppression of FFA prior to pregnancy, and in early (12-14 wks), and late (34-36 wks) gestation in four obese subjects with normal glucose tolerance and in five obese GDM subjects. In addition, abdominal subcutaneous adipose tissue biopsies were obtained at the time of cesarean delivery from normal obese pregnant (Preg-Con, n= 8), GDM (n = 7), and in non-pregnant obese control subjects during gynecologic surgery (Non-Preg Con, n = 7). GDM subjects tended to have higher starting basal plasma FFA prior to pregnancy (p =0.055). Insulin's ability to suppress FFA levels (based on percent suppression) declined from early to late gestation in both GDM and Preg-Con subjects, and was significantly less in GDM subjects compared to Preg-Con subjects over time (P=0.025). Normal pregnancy was not associated with decreased insulin signaling protein levels in adipose tissue compared to non-pregnant controls, indicating that declining insulin regulation of lipolysis over time could be due to a change in protein activity. In contrast, despite no differences in hormonal milieau, GDM subjects' adipose tissue IRS-1 protein levels were 43% lower (P=0.02) and p85{alpha} subunit of PI 3-kinase was 2 fold higher (p =0.03) in adipocytes compared with Preg-Con subjects. The steady-state levels of PPAR{gamma} mRNA were lower by 38% in Preg-Con (P= 0.006) and by 48% in GDM subjects (P=0.005) compared to Non-Preg controls. UCP2 mRNA levels were lower by 38% in Preg-Con and by 48% in GDM subjects compared to Non-Preg Con, while GDM subjects demonstrated a 73% and 52% reduction LPL and aP2 mRNA levels compared with Preg-Con subjects (p<0.002). These results demonstrate that GDM women, matched for obesity, have decreased IRS-1 as well as increased p85a protein content, both of which may contribute to their greater insulin resistance and reduced ability of insulin to suppress lipolysis with advancing gestation. The down-regulation of PPAR{gamma} mRNA expression and related genes in late pregnancy is consistent with insulin resistance and could be an important mechanism underlying the changes in lipid storage during the transition from early to late pregnancy.




This article has been cited by other articles:


Home page
DiabetesHome page
J. E. Friedman, J. P. Kirwan, M. Jing, L. Presley, and P. M. Catalano
Increased Skeletal Muscle Tumor Necrosis Factor-{alpha} and Impaired Insulin Signaling Persist in Obese Women With Gestational Diabetes Mellitus 1 Year Postpartum
Diabetes, March 1, 2008; 57(3): 606 - 613.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. R. Waites, M. A. Dominick, T. P. Sanderson, and B. E. Schilling
Nonclinical Safety Evaluation of Muraglitazar, a Novel PPAR{alpha}/{gamma} Agonist
Toxicol. Sci., November 1, 2007; 100(1): 248 - 258.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
L. A. Barbour, C. E. McCurdy, T. L. Hernandez, J. P. Kirwan, P. M. Catalano, and J. E. Friedman
Cellular Mechanisms for Insulin Resistance in Normal Pregnancy and Gestational Diabetes
Diabetes Care, July 1, 2007; 30(Supplement_2): S112 - S119.
[Full Text] [PDF]


Home page
Diabetes CareHome page
G. Desoye and S. Hauguel-de Mouzon
The Human Placenta in Gestational Diabetes Mellitus: The insulin and cytokine network
Diabetes Care, July 1, 2007; 30(Supplement_2): S120 - S126.
[Full Text] [PDF]


Home page
Diabetes CareHome page
M. Hod and Y. Yogev
Goals of Metabolic Management of Gestational Diabetes: Is it all about the sugar?
Diabetes Care, July 1, 2007; 30(Supplement_2): S180 - S187.
[Full Text] [PDF]


Home page
DiabetesHome page
J.-P. del Rincon, K. Iida, B. D. Gaylinn, C. E. McCurdy, J. W. Leitner, L. A. Barbour, J. J. Kopchick, J. E. Friedman, B. Draznin, and M. O. Thorner
Growth Hormone Regulation of p85{alpha} Expression and Phosphoinositide 3-Kinase Activity in Adipose Tissue: Mechanism for Growth Hormone-Mediated Insulin Resistance
Diabetes, June 1, 2007; 56(6): 1638 - 1646.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. N.M. Weijers and D. J. Bekedam
Relationship between Gestational Diabetes Mellitus and Type 2 Diabetes: Evidence of Mitochondrial Dysfunction
Clin. Chem., March 1, 2007; 53(3): 377 - 383.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. C. Connolly, T. Papa, M. S. Smith, D. B. Lacy, P. E. Williams, and M. C. Moore
Hepatic and muscle insulin action during late pregnancy in the dog
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R447 - R452.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. B. Tanko, J. M. Bruun, P. Alexandersen, Y. Z. Bagger, B. Richelsen, C. Christiansen, and P. J. Larsen
Novel Associations Between Bioavailable Estradiol and Adipokines in Elderly Women With Different Phenotypes of Obesity: Implications for Atherogenesis
Circulation, October 12, 2004; 110(15): 2246 - 2252.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2001 by the American Physiological Society.